[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=a333d19db878f507ab74a1faca7ee14a99e055f9a1e9dcdbd9691e6ffd9c0931",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741365660,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains",
      "id": 133155193,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=a333d19db878f507ab74a1faca7ee14a99e055f9a1e9dcdbd9691e6ffd9c0931"
    }
  },
  {
    "ts": null,
    "headline": "REGN Deadline: REGN Investors with Losses in Excess of $100K Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, March 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30,...",
    "url": "https://finnhub.io/api/news?id=43f337a7623fcea3af67a4d5e5168093a0f6488ed2370ffb5312b5e407cc0009",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741361764,
      "headline": "REGN Deadline: REGN Investors with Losses in Excess of $100K Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
      "id": 133100135,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, March 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30,...",
      "url": "https://finnhub.io/api/news?id=43f337a7623fcea3af67a4d5e5168093a0f6488ed2370ffb5312b5e407cc0009"
    }
  },
  {
    "ts": null,
    "headline": "Deadline Soon: Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
    "summary": "The Law Offices of Frank R. Cruz reminds investors of the upcoming March 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors...",
    "url": "https://finnhub.io/api/news?id=41db90c04be8d6bb808d4cbaa9aa33a277077b8c387a87b631858b274f969e7a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741348924,
      "headline": "Deadline Soon: Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
      "id": 133091430,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "The Law Offices of Frank R. Cruz reminds investors of the upcoming March 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors...",
      "url": "https://finnhub.io/api/news?id=41db90c04be8d6bb808d4cbaa9aa33a277077b8c387a87b631858b274f969e7a"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals",
    "summary": "Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=24b2004c0e3a698a7c298fff5733cee9a950cc7ee110669e8566c987863a6fab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741334340,
      "headline": "The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals",
      "id": 133186695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=24b2004c0e3a698a7c298fff5733cee9a950cc7ee110669e8566c987863a6fab"
    }
  },
  {
    "ts": null,
    "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, March 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ...",
    "url": "https://finnhub.io/api/news?id=17c9bfb4294d0106ee96ac91b5338152fed0e66986f03a467362390021608689",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741316525,
      "headline": "REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 133085242,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "LOS ANGELES, March 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ...",
      "url": "https://finnhub.io/api/news?id=17c9bfb4294d0106ee96ac91b5338152fed0e66986f03a467362390021608689"
    }
  }
]